People News: Novartis and Merck

Share this article:
Novartis' Daniel Vasella handed over the chief executive role to Joe Jimenez, who headed the company's pharmaceuticals division, in February. Vasella continues to serve as chairman of the board. The change completes a succession plan which began in 2008. David Epstein, previously head of oncology, replaces Jimenez as head of pharmaceuticals.
 
Merck hired Bridgette P. Heller to head the company's consumer health division. Heller joins Merck from Johnson & Johnson, where she was president of the baby global business unit since 2007. She was previously global president, baby, kids and wound care. At Merck, she will be EVP and president, consumer healthcare, reporting to chairman, president and CEO Dick Clark. She succeeds Stanley F. Barshay, who is retiring.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media